Search - tctmd.com

Displaying 161 - 180 of 369

Sort: Relevancy | Date

News Daily News

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

L.A. McKeown

February 16, 2016

Presentation TCT 2015

PANDA III: A Prospective Randomized Trial of Two Sirolimus-Eluting Bioresorbable-Polymer-Based Metallic Stents With Varying Elution and Absorption Kinetics

Presenter: Cindy L. Grines, Bo Xu

October 14, 2015

Presentation TCT 2015

Sirolimus-Eluting Angioplasty Balloon for In-Stent Restenosis (SABRE Trial): Six-Month Clinical and Angiographic Results

Presenter: Andrea Abizaid, Daniel Burkhoff, Juan F. Granada

October 14, 2015

Presentation TCT 2015

PANDA III: A Prospective Randomized Trial of 2 Sirolimus-Eluting Bioresorbable-Polymer–Based Metallic Stents With Varying Elution and Absorption Kinetics

Presenter: Bo Xu

October 14, 2015

Presentation TCT 2015

TCT 81: Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable-Polymer Sirolimus-Eluting Stent A Randomized Substudy of the I-LOVE-IT 2 Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Yaling Han

October 13, 2015

Presentation TCT 2015

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions Insights From the I-LOVE-IT 2 Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Bo Xu

October 13, 2015

Presentation TCT 2015

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold - Six-Month Clinical, Angiographic and Imaging Outcomes

Presenter: Ioanna Kosmidou, Michael Haude

October 12, 2015

Presentation TCT 2015

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold Six-Month Clinical, Angiographic, and Imaging Outcomes

Presenter: Dean J. Kereiakes, Ron Waksman, Davide Capodanno, Michael Haude

October 12, 2015

News Daily News

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

L.A. McKeown

July 20, 2015

News Daily News

Meta-analysis Confirms Late Safety of Second-Generation DES

L.A. McKeown

June 10, 2015

News Daily News

BRS Strut Width Tied to Increased Periprocedural MI

June 02, 2015

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Industry News

STENTYS: First Clinical Experience with Xposition shows 100% implantation success, Confirms Ease of Use

May 20, 2015

News Conference News EuroPCR 2015

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Caitlin E. Cox

May 20, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

STENTYS' Next-Generation of Self-Apposing Stent System Receives CE Marking Ahead of Plan

April 28, 2015

News Daily News

Timing of Stent Thrombosis Influences Its Relationship With Mortality

Todd Neale

April 03, 2015

News Daily News

Postdilation May Improve Outcomes After Self-Expanding Stent Is Used in Primary PCI

L.A. McKeown

March 18, 2015

News Conference News ACC 2015

Outcomes at 5 Years Reinforce Durability of Stenting for Unprotected Left Main Disease

L.A. McKeown

March 15, 2015

News Daily News

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

March 04, 2015

Advertisement

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

PANDA III: A Prospective Randomized Trial of Two Sirolimus-Eluting Bioresorbable-Polymer-Based Metallic Stents With Varying Elution and Absorption Kinetics

Sirolimus-Eluting Angioplasty Balloon for In-Stent Restenosis (SABRE Trial): Six-Month Clinical and Angiographic Results

PANDA III: A Prospective Randomized Trial of 2 Sirolimus-Eluting Bioresorbable-Polymer–Based Metallic Stents With Varying Elution and Absorption Kinetics

TCT 81: Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable-Polymer Sirolimus-Eluting Stent A Randomized Substudy of the I-LOVE-IT 2 Trial

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions Insights From the I-LOVE-IT 2 Trial

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold - Six-Month Clinical, Angiographic and Imaging Outcomes

BIOSOLVE II: Evaluation of a Sirolimus-Eluting Bioresorbable Metallic Scaffold Six-Month Clinical, Angiographic, and Imaging Outcomes

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

Meta-analysis Confirms Late Safety of Second-Generation DES

BRS Strut Width Tied to Increased Periprocedural MI

Trials Explore the Potential of Biodegradable-Polymer Stents

STENTYS: First Clinical Experience with Xposition shows 100% implantation success, Confirms Ease of Use

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

STENTYS' Next-Generation of Self-Apposing Stent System Receives CE Marking Ahead of Plan

Timing of Stent Thrombosis Influences Its Relationship With Mortality

Postdilation May Improve Outcomes After Self-Expanding Stent Is Used in Primary PCI

Outcomes at 5 Years Reinforce Durability of Stenting for Unprotected Left Main Disease

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content